US20050019851A1 - Use of VLCFAE for identifying herbicidally active compounds - Google Patents
Use of VLCFAE for identifying herbicidally active compounds Download PDFInfo
- Publication number
- US20050019851A1 US20050019851A1 US10/927,237 US92723704A US2005019851A1 US 20050019851 A1 US20050019851 A1 US 20050019851A1 US 92723704 A US92723704 A US 92723704A US 2005019851 A1 US2005019851 A1 US 2005019851A1
- Authority
- US
- United States
- Prior art keywords
- plant
- polypeptide
- vlcfae
- polypeptides
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000001875 compounds Chemical class 0.000 title abstract description 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 95
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 92
- 229920001184 polypeptide Polymers 0.000 claims abstract description 86
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 47
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 44
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 44
- 230000004071 biological effect Effects 0.000 claims abstract description 20
- 150000004669 very long chain fatty acids Chemical class 0.000 claims abstract description 12
- 101000813110 Mus musculus Elongation of very long chain fatty acids protein 6 Proteins 0.000 claims abstract description 9
- 230000002363 herbicidal effect Effects 0.000 claims description 22
- 230000001965 increasing effect Effects 0.000 claims description 12
- 230000000694 effects Effects 0.000 claims description 11
- 239000004009 herbicide Substances 0.000 claims description 10
- 239000005531 Flufenacet Substances 0.000 claims description 7
- IANUJLZYFUDJIH-UHFFFAOYSA-N flufenacet Chemical compound C=1C=C(F)C=CC=1N(C(C)C)C(=O)COC1=NN=C(C(F)(F)F)S1 IANUJLZYFUDJIH-UHFFFAOYSA-N 0.000 claims description 7
- 230000003834 intracellular effect Effects 0.000 claims description 3
- 230000002255 enzymatic effect Effects 0.000 claims 2
- 238000000034 method Methods 0.000 abstract description 24
- 241000196324 Embryophyta Species 0.000 description 57
- 108090000623 proteins and genes Proteins 0.000 description 38
- 210000004027 cell Anatomy 0.000 description 24
- 241000219194 Arabidopsis Species 0.000 description 20
- 102000004169 proteins and genes Human genes 0.000 description 19
- 108020004414 DNA Proteins 0.000 description 18
- 102000053602 DNA Human genes 0.000 description 18
- 230000014509 gene expression Effects 0.000 description 18
- 125000003275 alpha amino acid group Chemical group 0.000 description 16
- 239000013543 active substance Substances 0.000 description 14
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 13
- 230000004927 fusion Effects 0.000 description 12
- 239000013598 vector Substances 0.000 description 11
- 239000000126 substance Substances 0.000 description 10
- 239000000758 substrate Substances 0.000 description 10
- 102000036181 Fatty Acid Elongases Human genes 0.000 description 9
- 108010058732 Fatty Acid Elongases Proteins 0.000 description 9
- 239000012634 fragment Substances 0.000 description 9
- 150000001413 amino acids Chemical class 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 239000003446 ligand Substances 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 241000219195 Arabidopsis thaliana Species 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 210000000056 organ Anatomy 0.000 description 7
- 108091034117 Oligonucleotide Proteins 0.000 description 6
- 239000000556 agonist Substances 0.000 description 6
- 239000005557 antagonist Substances 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 125000003729 nucleotide group Chemical class 0.000 description 6
- 102000040430 polynucleotide Human genes 0.000 description 6
- 108091033319 polynucleotide Proteins 0.000 description 6
- 239000002157 polynucleotide Substances 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 230000009261 transgenic effect Effects 0.000 description 6
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 230000035772 mutation Effects 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- 238000005755 formation reaction Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 244000075850 Avena orientalis Species 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
- 108091092195 Intron Proteins 0.000 description 3
- 241000207783 Ipomoea Species 0.000 description 3
- 108010052285 Membrane Proteins Proteins 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 108020001507 fusion proteins Proteins 0.000 description 3
- 102000037865 fusion proteins Human genes 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 210000001236 prokaryotic cell Anatomy 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 101710114719 3-ketoacyl-CoA synthase 1 Proteins 0.000 description 2
- 102100022089 Acyl-[acyl-carrier-protein] hydrolase Human genes 0.000 description 2
- 235000005781 Avena Nutrition 0.000 description 2
- 101150069344 CUT1 gene Proteins 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000005720 Glutathione transferase Human genes 0.000 description 2
- 108010070675 Glutathione transferase Proteins 0.000 description 2
- 101000625842 Homo sapiens Tubulin-specific chaperone E Proteins 0.000 description 2
- 235000021506 Ipomoea Nutrition 0.000 description 2
- 241000227653 Lycopersicon Species 0.000 description 2
- 102000018697 Membrane Proteins Human genes 0.000 description 2
- 101100280636 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) fae-1 gene Proteins 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 241000209094 Oryza Species 0.000 description 2
- 241000209117 Panicum Species 0.000 description 2
- 235000006443 Panicum miliaceum subsp. miliaceum Nutrition 0.000 description 2
- 235000009037 Panicum miliaceum subsp. ruderale Nutrition 0.000 description 2
- 241000209056 Secale Species 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 102100024769 Tubulin-specific chaperone E Human genes 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 210000004671 cell-free system Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- VXIVSQZSERGHQP-UHFFFAOYSA-N chloroacetamide Chemical class NC(=O)CCl VXIVSQZSERGHQP-UHFFFAOYSA-N 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 210000001339 epidermal cell Anatomy 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 238000013537 high throughput screening Methods 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 150000004668 long chain fatty acids Chemical class 0.000 description 2
- -1 malonyl-CoA ester Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 239000006225 natural substrate Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 210000001938 protoplast Anatomy 0.000 description 2
- 229920002477 rna polymer Polymers 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 210000005253 yeast cell Anatomy 0.000 description 2
- 101150084750 1 gene Proteins 0.000 description 1
- ZBMRKNMTMPPMMK-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid;azane Chemical compound [NH4+].CP(O)(=O)CCC(N)C([O-])=O ZBMRKNMTMPPMMK-UHFFFAOYSA-N 0.000 description 1
- 101710161460 3-oxoacyl-[acyl-carrier-protein] synthase Proteins 0.000 description 1
- 230000005730 ADP ribosylation Effects 0.000 description 1
- 241000219144 Abutilon Species 0.000 description 1
- 108700037654 Acyl carrier protein (ACP) Proteins 0.000 description 1
- 102000048456 Acyl carrier protein (ACP) Human genes 0.000 description 1
- 101710144623 Acyl-[acyl-carrier-protein] hydrolase Proteins 0.000 description 1
- 241000209758 Aegilops Species 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 241000209136 Agropyron Species 0.000 description 1
- 241000743339 Agrostis Species 0.000 description 1
- CXISPYVYMQWFLE-VKHMYHEASA-N Ala-Gly Chemical compound C[C@H]([NH3+])C(=O)NCC([O-])=O CXISPYVYMQWFLE-VKHMYHEASA-N 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 241000743985 Alopecurus Species 0.000 description 1
- 241000219318 Amaranthus Species 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 241001547866 Anoda Species 0.000 description 1
- 241000404028 Anthemis Species 0.000 description 1
- 241001666377 Apera Species 0.000 description 1
- 241000581616 Aphanes Species 0.000 description 1
- 235000003911 Arachis Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- HCAUEJAQCXVQQM-ACZMJKKPSA-N Asn-Glu-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O HCAUEJAQCXVQQM-ACZMJKKPSA-N 0.000 description 1
- 235000005340 Asparagus officinalis Nutrition 0.000 description 1
- 241000219305 Atriplex Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000132028 Bellis Species 0.000 description 1
- 241000143476 Bidens Species 0.000 description 1
- 241000611157 Brachiaria Species 0.000 description 1
- 241000339490 Brachyachne Species 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 235000011331 Brassica Nutrition 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- 241000209200 Bromus Species 0.000 description 1
- 241000220244 Capsella <angiosperm> Species 0.000 description 1
- 241000320316 Carduus Species 0.000 description 1
- 241000701489 Cauliflower mosaic virus Species 0.000 description 1
- 241000209120 Cenchrus Species 0.000 description 1
- 241000132570 Centaurea Species 0.000 description 1
- 241000219312 Chenopodium Species 0.000 description 1
- 235000000509 Chenopodium ambrosioides Nutrition 0.000 description 1
- 244000098897 Chenopodium botrys Species 0.000 description 1
- 235000005490 Chenopodium botrys Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 241000132536 Cirsium Species 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 241000207892 Convolvulus Species 0.000 description 1
- 244000024469 Cucumis prophetarum Species 0.000 description 1
- 235000010071 Cucumis prophetarum Nutrition 0.000 description 1
- 241000219122 Cucurbita Species 0.000 description 1
- 241000234653 Cyperus Species 0.000 description 1
- ZGERHCJBLPQPGV-ACZMJKKPSA-N Cys-Ser-Gln Chemical compound C(CC(=O)N)[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CS)N ZGERHCJBLPQPGV-ACZMJKKPSA-N 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- 241000320605 Dactyloctenium Species 0.000 description 1
- 241000208296 Datura Species 0.000 description 1
- 241000208175 Daucus Species 0.000 description 1
- 241000522190 Desmodium Species 0.000 description 1
- 235000017896 Digitaria Nutrition 0.000 description 1
- 241001303487 Digitaria <clam> Species 0.000 description 1
- 241000192043 Echinochloa Species 0.000 description 1
- 241000202829 Eleocharis Species 0.000 description 1
- 241000209215 Eleusine Species 0.000 description 1
- 235000007351 Eleusine Nutrition 0.000 description 1
- 102100032052 Elongation of very long chain fatty acids protein 5 Human genes 0.000 description 1
- 108050007807 Elongation of very long chain fatty acids protein 5 Proteins 0.000 description 1
- 244000294661 Emex spinosa Species 0.000 description 1
- 235000006369 Emex spinosa Nutrition 0.000 description 1
- 241001518935 Eragrostis Species 0.000 description 1
- 241000044408 Eriochloa Species 0.000 description 1
- 241000919496 Erysimum Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000221079 Euphorbia <genus> Species 0.000 description 1
- 108091092566 Extrachromosomal DNA Proteins 0.000 description 1
- 241000234642 Festuca Species 0.000 description 1
- 241001290564 Fimbristylis Species 0.000 description 1
- 241000816457 Galeopsis Species 0.000 description 1
- 241000748465 Galinsoga Species 0.000 description 1
- 241001101998 Galium Species 0.000 description 1
- FTIJVMLAGRAYMJ-MNXVOIDGSA-N Gln-Ile-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCC(N)=O FTIJVMLAGRAYMJ-MNXVOIDGSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 235000009438 Gossypium Nutrition 0.000 description 1
- 241000219146 Gossypium Species 0.000 description 1
- 241000208818 Helianthus Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- RXVOMIADLXPJGW-GUBZILKMSA-N His-Asp-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O RXVOMIADLXPJGW-GUBZILKMSA-N 0.000 description 1
- 241000209219 Hordeum Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 241000169108 Hydrothrix Species 0.000 description 1
- 240000007171 Imperata cylindrica Species 0.000 description 1
- 241001327265 Ischaemum Species 0.000 description 1
- 241000110847 Kochia Species 0.000 description 1
- 241000235058 Komagataella pastoris Species 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- TYYLDKGBCJGJGW-UHFFFAOYSA-N L-tryptophan-L-tyrosine Natural products C=1NC2=CC=CC=C2C=1CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 TYYLDKGBCJGJGW-UHFFFAOYSA-N 0.000 description 1
- 241000208822 Lactuca Species 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 241000520028 Lamium Species 0.000 description 1
- 241000801118 Lepidium Species 0.000 description 1
- 241000320639 Leptochloa Species 0.000 description 1
- 241000208204 Linum Species 0.000 description 1
- 241000209082 Lolium Species 0.000 description 1
- 235000002262 Lycopersicon Nutrition 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- LTYOQGRJFJAKNA-KKIMTKSISA-N Malonyl CoA Natural products S(C(=O)CC(=O)O)CCNC(=O)CCNC(=O)[C@@H](O)C(CO[P@](=O)(O[P@](=O)(OC[C@H]1[C@@H](OP(=O)(O)O)[C@@H](O)[C@@H](n2c3ncnc(N)c3nc2)O1)O)O)(C)C LTYOQGRJFJAKNA-KKIMTKSISA-N 0.000 description 1
- 235000017945 Matricaria Nutrition 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 235000014435 Mentha Nutrition 0.000 description 1
- 241001072983 Mentha Species 0.000 description 1
- 241000221024 Mercurialis Species 0.000 description 1
- 235000003990 Monochoria hastata Nutrition 0.000 description 1
- 240000000178 Monochoria vaginalis Species 0.000 description 1
- 241001442129 Myosotis Species 0.000 description 1
- 241000208125 Nicotiana Species 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000011096 Papaver Nutrition 0.000 description 1
- 240000001090 Papaver somniferum Species 0.000 description 1
- 241001268782 Paspalum dilatatum Species 0.000 description 1
- 241000745991 Phalaris Species 0.000 description 1
- 241000219833 Phaseolus Species 0.000 description 1
- DEZCWWXTRAKZKJ-UFYCRDLUSA-N Phe-Phe-Met Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCSC)C(O)=O DEZCWWXTRAKZKJ-UFYCRDLUSA-N 0.000 description 1
- IPVPGAADZXRZSH-RNXOBYDBSA-N Phe-Tyr-Trp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O IPVPGAADZXRZSH-RNXOBYDBSA-N 0.000 description 1
- BQMFWUKNOCJDNV-HJWJTTGWSA-N Phe-Val-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BQMFWUKNOCJDNV-HJWJTTGWSA-N 0.000 description 1
- 241000746981 Phleum Species 0.000 description 1
- 241000195887 Physcomitrella patens Species 0.000 description 1
- 241000219843 Pisum Species 0.000 description 1
- 241001127637 Plantago Species 0.000 description 1
- 241000209048 Poa Species 0.000 description 1
- 241000205407 Polygonum Species 0.000 description 1
- 241000219295 Portulaca Species 0.000 description 1
- FDINZVJXLPILKV-DCAQKATOSA-N Pro-His-Asn Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(O)=O FDINZVJXLPILKV-DCAQKATOSA-N 0.000 description 1
- 108020004518 RNA Probes Proteins 0.000 description 1
- 239000003391 RNA probe Substances 0.000 description 1
- 241000218206 Ranunculus Species 0.000 description 1
- 241000220259 Raphanus Species 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 241000490453 Rorippa Species 0.000 description 1
- 241000341978 Rotala Species 0.000 description 1
- 241000857233 Rottboellia Species 0.000 description 1
- 241000219053 Rumex Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 240000009132 Sagittaria sagittifolia Species 0.000 description 1
- 241001632050 Salsola Species 0.000 description 1
- 241000202758 Scirpus Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 241000228160 Secale cereale x Triticum aestivum Species 0.000 description 1
- 241000780602 Senecio Species 0.000 description 1
- QFBNNYNWKYKVJO-DCAQKATOSA-N Ser-Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CCCN=C(N)N QFBNNYNWKYKVJO-DCAQKATOSA-N 0.000 description 1
- 244000275012 Sesbania cannabina Species 0.000 description 1
- 235000005775 Setaria Nutrition 0.000 description 1
- 241000232088 Setaria <nematode> Species 0.000 description 1
- 241000220261 Sinapis Species 0.000 description 1
- 235000002634 Solanum Nutrition 0.000 description 1
- 241000207763 Solanum Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 241000488874 Sonchus Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 244000273618 Sphenoclea zeylanica Species 0.000 description 1
- 235000017967 Sphenoclea zeylanica Nutrition 0.000 description 1
- 240000006694 Stellaria media Species 0.000 description 1
- 241000245665 Taraxacum Species 0.000 description 1
- 241000722118 Thlaspi Species 0.000 description 1
- GQPQJNMVELPZNQ-GBALPHGKSA-N Thr-Ser-Trp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N)O GQPQJNMVELPZNQ-GBALPHGKSA-N 0.000 description 1
- 108020004566 Transfer RNA Proteins 0.000 description 1
- 241000219793 Trifolium Species 0.000 description 1
- 235000019714 Triticale Nutrition 0.000 description 1
- GSCPHMSPGQSZJT-JYBASQMISA-N Trp-Ser-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N)O GSCPHMSPGQSZJT-JYBASQMISA-N 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 241000219422 Urtica Species 0.000 description 1
- GVJUTBOZZBTBIG-AVGNSLFASA-N Val-Lys-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N GVJUTBOZZBTBIG-AVGNSLFASA-N 0.000 description 1
- 241000219873 Vicia Species 0.000 description 1
- 241001506766 Xanthium Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 241000209149 Zea Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 244000193174 agave Species 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000009435 amidation Effects 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 210000004507 artificial chromosome Anatomy 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000033077 cellular process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 244000038559 crop plants Species 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000032459 dedifferentiation Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000017858 demethylation Effects 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 101150086278 fdh gene Proteins 0.000 description 1
- 150000002211 flavins Chemical class 0.000 description 1
- 238000002875 fluorescence polarization Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000022244 formylation Effects 0.000 description 1
- 238000006170 formylation reaction Methods 0.000 description 1
- 230000006251 gamma-carboxylation Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 108010042598 glutamyl-aspartyl-glycine Proteins 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 230000026045 iodination Effects 0.000 description 1
- 238000006192 iodination reaction Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- LTYOQGRJFJAKNA-DVVLENMVSA-N malonyl-CoA Chemical class O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 LTYOQGRJFJAKNA-DVVLENMVSA-N 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 210000001589 microsome Anatomy 0.000 description 1
- 208000024191 minimally invasive lung adenocarcinoma Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004001 molecular interaction Effects 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 230000007498 myristoylation Effects 0.000 description 1
- 210000000287 oocyte Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000005648 plant growth regulator Substances 0.000 description 1
- 238000004161 plant tissue culture Methods 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 230000001323 posttranslational effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 230000006337 proteolytic cleavage Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 230000009131 signaling function Effects 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 150000003558 thiocarbamic acid derivatives Chemical class 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 108010044292 tryptophyltyrosine Proteins 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B30/00—Methods of screening libraries
- C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H3/00—Processes for modifying phenotypes, e.g. symbiosis with bacteria
- A01H3/04—Processes for modifying phenotypes, e.g. symbiosis with bacteria by treatment with chemicals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8274—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for herbicide resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/91045—Acyltransferases (2.3)
- G01N2333/91051—Acyltransferases other than aminoacyltransferases (general) (2.3.1)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Definitions
- the invention relates to the use of nucleic acids which code for plant polypeptides with the biological activity of very long chain fatty acid elongases and to the use of the polypeptides encoded thereby for identifying novel, herbicidally active compounds, and to methods for finding modulators of these polypeptides.
- Fatty acid elongases are also referred to as 3-ketoacyl-CoA-synthases or as “condensing enzymes”.
- Very long chain fatty acid elongases abbreviated to VLCFAE hereinafter, are responsible for the biosynthesis of fatty acids with a chain length of more than 18 C atoms.(Millar, A. A. and Kunststoff, L. 1997, The Plant Journal 12(1), 121-131).
- the substrates recognized by VLCFAE apart from malonyl-CoA ester are only fatty acid-CoA esters with chain lengths of greater than or equal to C 18 (C 18+), and the proteins are probably microsomally associated in the cytoplasm.
- VLCFA Long-Chain Fatty Acids
- VLCFA Long-Chain Fatty Acids
- VLCFA are components and precursors of the wax layer in the cuticle of plants. They may be components and precursors of cell membranes or constituents of specific storage triacylglycerides. However, they may also be constituents or precursors of lipids with a signal function or with a second messenger function in the plant, such as, for example, the sphingolipids.
- VLCFAE are plant-specific genes which, for example in Arabidopsis, represent a complex family of genes.
- fiddlehead is specifically expressed in the epidermis, the outermost plant cell layer, and suppresses the dedifferentiation of these cells.
- Mutants in which the function of the FIDDLEHEAD-protein is impaired show fusions/adhesions of leaves and flower organs.
- the fusions/adhesions of the flower organs of a fiddlehead mutant resemble the scroll of a violin and gave this name to the mutant.
- Fiddlehead plants show considerable morphological changes and great impairments of development. (Lolle et al. 1992, Developmental Biology 152, 383-392, Yephremov et al.
- Epidermal cells are essentially involved in the fusion/adhesion. Moreover the cells fuse only via the extracellular layer, without fusion of the cytoplasm. Since epidermal cells are responsible for the formation of the extracellular cuticle, it must be assumed that the loss of function of fiddlehead leads to a change in the VLCFA components in the cuticle and this causes the organ fusions described.
- the nucleic acid coding for the FIDDLEHEAD polypeptide is available under the accession number AJ010713 or O64846 (GenEMBL) and is shown in WO 98/54954 and described in the present application under SEQ ID NO: 1.
- the diversity of the elongases, their substrate specificity and their tissue-specific expression makes it possible for plants to produce a wide variety of storage, cuticle and signal lipids.
- This synthetic diversity can be utilized in practice through heterologous gene expression in transgenic plants. It is moreover possible by gene transfer for the synthetic capacity due to an elongase with specific substrate specificity to be transferred from one plant species to another. On the other hand, it is also possible, for example by exchange of promoters, for the tissue-specific lipid synthesis to be deliberately changed within one plant species.
- Diverse publications deal with research of this type. (see, for example, WO 96/13582, WO 98/46766, WO 98/54954, WO 95/15387, WO 00/08172).
- the fiddlehead phenotype can be induced with a herbicidal active substance from the oxyacetamide class, flufenacet.
- the active substance phenocopies fiddlehead.
- the active substance also leads to fusion of the rosette leaves.
- FIDDLEHEAD a very long chain fatty acid elongase
- VLCFAE since the VLCFAE, in particular also FIDDLEHEAD from Arabidopsis and other plants, show extensive homologies with one another, it is also possible to use homologous polypeptides encoded by appropriate homologous nucleic acids, and other members of the gene family, as molecular interaction partners (targets) for herbicidal active substances and the aforementioned class of substances. It is thus possible for herbicidal active substances to interact with various VLCFAE, although the interaction with the various VLCFAE occurring in plants may not always have the same strength. This might explain inter alia the observed selectivity of the herbicide class.
- fatty acid elongases and beta-ketoacyl-CoA synthases from Arabidopsis which are homologous with FIDDLEHEAD (FDH) from Arabidopsis thaliana (Acc. No. AJ010713 or O64846) are listed by way of example and not definitively in the following table and in FIG. 1 .
- FDH FIDDLEHEAD
- FIG. 1 The degree of phylogenetic relationship between the genes shown can also be inferred qualitatively therefrom.
- VLCFAE are protein targets for herbicidal active substances and can be employed to identify novel, improved herbicidal active substances in methods (assays) suitable for this purpose.
- polypeptides from plants showing a homology to the FIDDLEHEAD (FDH) polypeptide from Arabidopsis preferably encompassing polypeptides with a homology of 60%, particularly preferably of 80% and very particularly preferably of 90%, to FDH.
- FDH-homologous VLCFAE from Arabidopsis for identifying novel, herbicidal active substances, preferably encompassing polypeptides with a homology of 60%, particularly preferably of 80% and very particularly preferably of 90%, to FDH.
- FDH polypeptide from Arabidopsis it is possible in a very particularly preferred manner for the FDH polypeptide from Arabidopsis to be used to identify novel herbicidal active substances.
- the present invention therefore relates to the use of plant polypeptides with the biological activity of a VLCFAE for identifying VLCFAE modulators.
- the present invention likewise relates to the use of plant polypeptides with the biological activity of a VLCFAE having a homology of 60%, preferably of 80% and particularly preferably of 90% to the FDH polypeptide from Arabidopsis for identifying VLCFAE modulators.
- the present invention likewise relates to the use of polypeptides from Arabidopsis with the biological activity of a VLCFAE which have a homology of 60%, preferably of 80% and particularly preferably of 90% to the FDH polypeptide from Arabidopsis for identifying VLCFAE modulators.
- the present invention relates in particular to the use of the FIDDLEHEAD polypeptide having SEQ ID NO: 2 for identifying VLCFAE modulators.
- the present invention likewise relates to the use of nucleic acids encoding for VLCFAE for identifying VLCFAE modulators.
- the present invention likewise relates to the use of nucleic acids coding for VLCFAE and having a homology to the fiddlehead sequence according to a coding sequence of SEQ ID NO: 1 of 60%, preferably of 80% and particularly preferably of 90% for identifying VLCFAE modulators. Homologues of Arabidopsis are particularly preferred in this connection.
- the present invention relates in particular also to the use of the nucleic acid coding for the FIDDLEHEAD polypeptide and having SEQ ID NO: 1 for identifying VLCFAE modulators.
- polynucleotides or polynucleotide fragments to be used according to the invention are preferably those corresponding to polynucleotides from plants.
- polynucleotides or polynucleotide fragments to be used according to the invention are particularly preferably those corresponding to polynucleotides from Arabidopsis.
- polypeptides to be used according to the invention very particularly preferably include a sequence selected from
- a very particularly preferred embodiment of the nucleic acids to be used according to the invention is represented by a cDNA molecule having the FDH-encoding sequence shown in SEQ ID NO: 1, the introns shown in SEQ ID NO: 1 no longer being present.
- the FDH-encoding regions of the nucleic acid shown in SEQ ID NO: 1 extend from position 176-583, 1119-1745 and 1821-2438.
- nucleic acids to be used according to the invention are, in particular, single-stranded or double-stranded deoxyribonucleic acids (DNA) or ribonucleic acids (RNA).
- DNA deoxyribonucleic acids
- RNA ribonucleic acids
- Preferred embodiments are fragments of genomic DNA, which may contain introns as shown in SEQ ID NO: 1 and cDNAs.
- the nucleic acids to be used according to the invention are preferably DNA or DNA fragments corresponding to genomic DNA from plants.
- the nucleic acids to be used according to the invention are particularly preferably DNA or DNA fragments corresponding to genomic DNA from Arabidopsis.
- nucleic acids to be used according to the invention very particularly preferably include a sequence selected from
- a very particularly preferred embodiment of the nucleic acids to be used according to the invention is represented by a cDNA molecule with the FDH-encoding sequence shown in SEQ ID NO: 1.
- to hybridize describes the process in which a single-stranded nucleic acid molecule enters into base pairing with a complementary strand. It is possible in this way, starting from the sequence information disclosed herein, for example to isolate DNA fragments from plants other than Arabidopsis which code for VLCFAE and, in particular, for FIDDLEHEAD, which have the same or similar properties of an elongase with the amino acid sequence shown in SEQ ID NO: 2.
- nucleic acid sequence coding for the N-terminal polypeptide sequence characteristic of FDH can be used in order to find nucleic acid sequences and polypeptides which are sequentially and functionally homologous to FDH and are suitable for identifying novel herbicidal active substances.
- Hybridization conditions are calculated approximately by the following formula:
- the melting temperature Tm 81.5° C.+16.6 log [c(Na + )]+0.41(% G+C)) ⁇ 500/n (Lottspeich and Zorbas, 1998).
- c is the concentration and n is the length of the hybridizing sequence section in basepairs.
- 500/n is omitted for a sequence of >100 bp.
- washing is carried out at a temperature of 5-15° C. below Tm and an ionic strength of 15 mM Na + (equivalent to 0.1 ⁇ SSC). If an RNA probe is used for the hybridization, then the melting point is 10-15° C. higher.
- Hybridization solution DIG Easy Hyb (supplied by Roche) Hybridization temperature: 37° C., preferably 42° C. (DNA-DNA), 50° C. (DNA-RNA).
- active site refers to a peptide region which functionally corresponds to the peptide region with an amino acid sequence from position 191 to position 310 of the sequence shown in SEQ ID NO: 2.
- the reactive amino acid cystein is located at position 257 .
- the degree of identity of the nucleic acids is preferably determined with the aid of the NCBI BLASTN program, version 2.0.4. (Altschul et al., 1997).
- the present invention also relates to the use, in methods for identifying VLCFAE inhibitors, of the regulatory regions which, in plant cells, especially in Arabidopsis, naturally control the transcription of the nucleic acids to be used according to the invention.
- regulatory regions refers to nontranslated regions of the relevant gene, such as promoters, enhancers, repressor or activator binding sites or termination sequences, which interact with cellular proteins, leading to control of transcription.
- the present invention further relates to the use of DNA constructs which include a nucleic acid to be used according to the invention and a heterologous promoter for identifying VLCFAE modulators.
- heterologous promoter refers to a promoter which has properties different from those of the promoter which controls expression of the relevant gene in the original organism.
- heterologous promoters depends on whether prokaryotic or eukaryotic cells or cell-free systems are used for expression.
- heterologous promoters are the 35S promoter of cauliflower mosaic virus for plant cells, the alcohol dehydrogenase promoter for yeast cells, the T3, T7 or SP6 promoters for prokaryotic cells or cell-free systems, and tissue-specific promoters from plants, for example the epidermis-specific promoter of FIDDLEHEAD and the promoters of other tissue-specific elongases.
- the present invention further relates to the use of vectors which contain a nucleic acid to be used according to the invention, a regulatory region to be used according to the invention or a DNA construct to be used according to the invention, in methods for identifying the VLCFAE modulators.
- Vectors which can be used are all phages, plasmids, phagemids, phasmids, cosmids, YACs, BACs, artificial chromosomes or particles suitable for particle bombardment which are used in molecular biology laboratories.
- Preferred vectors are pBIN (Bevan, 1984) and its derivatives for plant cells, pFL61 (Minet et al., 1992) or, for example, the p4XXprom vector series (Mumberg D., Müller R. and Funk M. 1995, Gene 156, 119-122) for yeast cells, pBLUESCRIPT-vectors for bacterial cells, lamdaZAP (from Stratagene) for phages.
- the present invention also relates to the use of host cells which contain a nucleic acid to be used according to the invention, a DNA construct to be used according to the invention or a vector to be used according to the invention, for identifying VLCFAE modulators.
- host cell refers to cells which do not naturally contain the nucleic acids to be used according to the invention and are suitable for expression of the polypeptide to be used according to the invention.
- Suitable host cells are both prokaryotic cells, preferably E. coli, and eukaryotic cells such as cells of Saccharomyces cerevisiae, Pichia pastoris, insects, plants, frog oocytes and mammalian cell lines.
- polypeptides refers both to short amino acid chains, which are usually referred to as peptides, oligopeptides or oligomers, and to longer amino acid chains which are usually referred to as proteins. It encompasses amino acid chains which may be modified either by natural processes, such as post-translational processing, or by chemical methods which are state of the art. Such modifications may occur at various points and a plurality of times in a polypeptide, such as, for example, on the peptide backbone, on the amino acid side chain, on the amino terminus and/or on the carboxyl terminus.
- acetylations comprise, for example, acetylations, acylations, ADP ribosylations, amidations, covalent linkages with flavins, haem portions, nucleotides or nucleotide derivatives, lipids or lipid derivatives or phosphatidylinositol, cyclizations, formation of disulphide bridges, demethylations, cystine formations, formylations, gamma-carboxylations, glycosylations, hydroxylations, iodinations, methylations, myristoylations, oxidations, proteolytic processings, phosphorylations, selenoylations and tRNA-mediated additions of amino acids.
- the peptides according to the invention may be in the form of “mature” proteins or in the form of parts of larger proteins, for example as fusion proteins. They may furthermore have secretion or “leader” sequences, prosequences, sequences which make simple purification possible, such as multiple histidine residues, or additional stabilizing amino acids.
- polypeptides to be used according to the invention need not be complete VLCFAE but may also be only fragments thereof as long as they still have a biological activity of the complete VLCFAE.
- Polypeptides which exercise a biological activity of the same type as a VLCFA-E with an amino acid sequence as shown in SEQ ID NO: 2 are also regarded as being according to the invention.
- the polypeptides to be used according to the invention moreover need not correspond to the VLCFAE from Arabidopsis.
- Monocotyledonous plants of the genera Allium, Ananas, Asparagus, Avena, Hordeum, Oryza, Panicum, Saccharurn, Secale, Triticale, Triticum, Zea.
- polypeptides to be used according to the invention may, by comparison with the corresponding region of naturally occurring VLCFAE, have deletions or amino acid substitutions as long as they still exercise the biological activity of the complete fatty acid elongases.
- Conservative substitutions are preferred.
- Such conservative substitutions comprise variations where one amino acid is replaced by another amino acid from the following group:
- the present invention thus also relates to the use of polypeptides which exercise the biological activity of a VLCFAE and comprise an amino acid sequence which shows at least 60% identity, preferably 80% identity, particularly preferably 90% identity and particularly preferably 97-99% identity with the sequence shown in SEQ ID NO: 2 over the entire length thereof.
- the degree of identity of the amino acid sequences is preferably determined with the aid of the BLASTP+BEAUTY programme, version 2.0 4. (Altschul et al., 1997).
- polypeptides to be used according to the invention is the VLCFAE FIDDLEHEAD (FDH) with an amino acid sequence as shown in SEQ ID NO: 2.
- the FDH amino acid sequence belongs on the basis of homology (Yephremov et al. 1999) to the family of fatty acid elongases (FAE).
- the FDH protein has two potential transmembranes domains in the region of the amino acids from about 53 to 75 and in the region from about 93 to 115.
- the first 45-50 amino acids at the N terminus are specific for the FIDDLEHEAD protein whose biological role has not as yet been fully elucidated.
- the N terminus is so specific that it can be used as recognition sequence for FDH.
- biological activity of a VLCFAE means the ability to biosynthesize fatty acids with a chain length of 18 and more C atoms, and to the recognition of the substrates malonyl-CoA esters and/or fatty acid CoA esters with chain lengths greater than or equal to C 18 .
- the nucleic acids to be used according to the invention can be prepared in the conventional way.
- the nucleic acid molecules can be completely chemically synthesized. It is also possible for short pieces of the nucleic acids according to the invention to be chemically synthesized and for such oligonucleotides to be labelled radioactively or with a fluorescent dye.
- the labelled oligonucleotides can also be used to screen cDNA banks produced starting from plant mRNA. Clones to which the labelled oligonucleotides hybridize are selected for isolating the relevant DNA fragments. After characterization of the isolated DNA, the nucleic acids to be used according to the invention are obtained in a simple manner.
- nucleic acids to be used according to the invention can also be prepared by PCR methods using chemically synthesized oligonucleotides.
- oligonucleotide(s) as used herein means DNA molecules consisting of 10 to SO nucleotides, preferably 15 to 30 nucleotides. They are chemically synthesized and can be used as probes.
- polypeptides to be used according to the invention which are encoded by the nucleic acids according to the invention can be prepared by cultivating, under suitable conditions, host cells which contain nucleic acids to be used according to the invention.
- the desired polypeptides can then be isolated in a conventional way from the cells or the culture medium.
- the polypeptides can also be prepared in in-vitro systems.
- a rapid method for isolating the polypeptides to be used according to the invention which are synthesized by host cells using a nucleic acid to be used according to the invention starts with the expression of a fusion protein where the fusion partner can be affinity-purified in a simple manner.
- the fuision partner can be, for example, glutathione S-transferase.
- the fusion protein can then be purified on a glutathione affinity column.
- the fusion partner can be removed by partial proteolytic cleavage for example at linkers between the fusion partner and the polypeptide according to the invention which is to be purified.
- the linker can be designed so that it includes target amino acids, such as arginine and lysine residues, which define sites for trypsin cleavage.
- target amino acids such as arginine and lysine residues, which define sites for trypsin cleavage.
- Such linkers can be generated by employing standard cloning methods using oligonucleotides.
- purification methods are based on preparative electrophoresis, FPLC, HPLC (for example using gel filtration, reverse phase or slightly hydrophobic columns), gel filtration, differential precipitation, ion exchange chromatography and affinity chromatography.
- VLCFAE membrane proteins or membrane-associated proteins
- detergent extractions are preferably carried out during the purification methods, for example using detergents which affect the secondary and tertiary structures of the polypeptides only slightly or not at all, such as nonionic detergents.
- Purification of the polypeptides to be used according to the invention may encompass the isolation of membranes starting from host cells which express the nucleic acids according to the invention.
- Such cells preferably express the polypeptides to be used according to the invention in an adequate copy number so that the amount of polypeptides in a membrane fraction is at least 10 times higher than that found in comparable membranes of cells which express the FDH gene naturally; the amount is particularly preferably 100 times, very particularly preferably at least 1000 times, higher.
- a membrane fraction in particular a microsome fraction
- a membrane fraction for assay purposes it is also possible for a membrane fraction, in particular a microsome fraction, to be concentrated and used without special purification.
- isolation or purification mean that the polypeptides to be used according to the invention are separated from other proteins or other macromolecules of the cell or of the tissue.
- a composition containing the polypeptides to be used according to the invention is preferably concentrated at least 10-fold and particularly preferably at least 100-fold in terms of the protein content by comparison with a preparation from the host cells.
- polypeptides to be used according to the invention can be affinity-purified even without fusion partners, with the aid of antibodies which bind to the polypeptides.
- the present invention also relates to methods for finding chemical compounds which bind to the polypeptides according to the invention and alter their properties. Because of the diverse functions of the VLCFAE according to the invention, modulators which influence the activity may represent novel growth-regulating or herbicidal active substances. Modulators may be agonists or antagonists, or inhibitors or activators.
- agonist refers to a molecule which promotes or enhances the VLCFAE activity.
- antagonist refers to a molecule which retards or impedes the VLCFAE activity.
- modulator as used herein represents the generic term for agonist and antagonist.
- Modulators may be small organic chemical molecules, peptides or antibodies which bind to/the polypeptides according to the invention. Modulators may furthermore be small organic chemical molecules, peptides or antibodies which bind to a molecule which in turn binds to the polypeptides according to the invention and thus influences their biological activity. Modulators may be natural substrates and ligands or structural or functional mimetics thereof.
- the modulators are preferably small organic chemical compounds.
- Binding of the modulators to the VLCFAE may alter the cellular processes in a way leading to death of the plants treated therewith.
- the present invention therefore also relates to VLCFAE modulators which have been found with the aid of a method described above for identifying modulators of the FDH protein or of a VLCFAE homologous thereto.
- the present invention further relates to methods for finding chemical compounds which alter the expression of the polypeptides to be used according to the invention.
- expression modulators may also represent novel growth-regulating or herbicidal active substances.
- Expression modulators may be small organic chemical molecules, peptides or antibodies which bind to the regulatory regions of the nucleic acids coding for the polypeptides to be used according to the invention.
- Expression modulators may furthermore be small organic chemical molecules, peptides or antibodies which bind to a molecule which in turn binds to regulatory regions of the nucleic acids coding for the polypeptides to be used according to the invention, and thus influences expression thereof.
- Expression modulators may also be antisense molecules.
- the present invention likewise relates to the use of modulators of the polypeptides to be used according to the invention or of expression modulators as plant growth regulators or herbicides.
- the present invention likewise relates to expression modulators of VLCFAE which are found with the aid of the method described above for finding expression modulators.
- the methods according to the invention include high-throughput screening (HTS). It is possible to use for this both host cells and cell-free preparations which contain the nucleic acids to be used according to the invention and/or the polypeptides to be used according to the invention.
- HTS high-throughput screening
- a synthetic reaction mix for example products of in vitro transcription
- a cellular constituent such as a membrane or any other preparation which contains the polypeptides to be used according to the invention
- a candidate molecule which may be an agonist or antagonist.
- the ability of the candidate molecule to increase or inhibit the activity of the polypeptides to be used according to the invention is evident from an increased or reduced binding of the labelled ligand or from an increased or reduced conversion of the labelled substrate.
- Molecules which bind well and lead to an increased activity of the polypeptides according to the invention are agonists.
- Molecules which bind well and inhibit the biological activity of the polypeptides to be used according to the invention are good antagonists. These may be inhibitors of the abovementioned classes of herbicidal substances without, however, being restricted thereto.
- Reporter systems in this regard comprise, but are not restricted to, calorimetrically labelled substrates which are converted into a product, or a reporter gene which responds to changes in the activity or the expression of the polypeptides to be used according to the invention, or other known binding assays.
- the activity of membrane-associated proteins can advantageously be measured in another way. Functional heterologous expression of such proteins in E coli is often difficult or impossible. In this case it is possible by suitable cloning (for example using suitable PCR strategies) to separate the catalytically active part of the protein from the membrane-associated part of the protein so that the gene product represents a soluble protein and can easily be purified.
- suitable cloning for example using suitable PCR strategies
- a wide repertoire of measurement possibilities is available for measuring the activity of soluble proteins. Particularly sensitive measurement can take place for example by fluorescence polarization with use of a fluorescence-labelled ligand or substrate.
- Another example of a method with which modulators of the polypeptides to be used according to the invention can be found is a displacement assay in which, under conditions suitable for this purpose, the polypeptides to be used according to the invention and a potential modulator are compacted with a molecule which is known to bind to the polypeptides to be used according to the invention, such as a natural substrate or ligand or a substrate or ligand mimetic.
- the substrate or ligand mimetic may be, for example, radioactively labelled or provided with a fluorescent or dye marker (also UV).
- polypeptides to be used according to the invention themselves can also be labelled in an analogous way so that the number of polypeptides which are bound to a ligand or have undergone a reaction can be determined accurately. It is possible in this way to estimate the efficacy of an agonist or antagonist.
- the invention further relates to the use of a nucleic acid to be used according to the invention, of a DNA construct to be used according to the invention or of a vector to be used according to the invention for producing transgenic plants, and to the corresponding transgenic plants as such or parts or propagation material thereof.
- the present invention likewise relates to transgenic plants, parts of plants, protoplasts, plant tissues or plant propagation materials in which, after introduction of a nucleic acid to be used according to the invention, of a DNA construct to be used according to the invention or of a vector to be used according to the invention, the intracellular concentration of VLCFAE is increased or reduced compared with the corresponding wild-type forms.
- parts of plants as used herein means all epigeal and hypogeal parts and organs of the plants, such as shoot, leaf, flower and root, and protoplasts and tissue cultures produced therefrom.
- propagation material means vegetative and generative propagation material such as cuttings, tubers, rhizomes, layers and seeds.
- the invention also relates to plants in which alterations are made in the sequence coding for VLCFAE leading to production of a VLCFAE which leads to an increase or reduction in the biological activity or the amount of the VLCFAE present in the plants.
- mutants refers to a method for increasing the spontaneous mutation rate and thus for isolating mutants. This may entail generation of mutants with the aid of mutagens in vivo, for example with chemical compounds or physical effects which are suitable for inducing mutations (for example base analogues, intercalating substances, UV rays etc.).
- the required mutants can be obtained by selection for a particular phenotype.
- the position of the mutations on the chromosomes can be determined relative to other known mutations by complementation and recombination analyses. Mutations can also be introduced in a targeted manner into chromosomal or extrachromosomal DNA (in vitro mutagenesis, site directed mutagenesis, error-prone PCR etc.).
- mutant refers to an organism which harbours an altered (mutated) gene.
- a mutant is defined by comparison with the wild-type which harbours the unaltered gene.
- VLCFAE to be used according to the invention plays a part in signalling and development processes
- transgenic “sense” plants or plants which have been selected deliberately for an increased amount or activity of corresponding endogenous VLCFAE or elements linked thereto in the signal transduction acquire increased resistance to herbicidally active compounds. It is also possible by mutating the amino acid sequence to develop VLCFAE which are resistant to compounds having herbicidal activity on these proteins.
- Arabidopsis seeds (ecotype Columbia Col-0), which were stored at 4° C., were sown in soil and cultivated at 22° C. ⁇ 2° C. under long-day conditions (16 h light/8 h dark).
- Plants 2 weeks old were sprayed with 250 g/ha and 50 g/ha flufenacet and cultivated further at 22° C. ⁇ 2° C. under long-day conditions (16 h light/8 h dark).
- the flower organs fuse with the uppermost cauline leaves of the Arabidopsis plants. These fusions are very similar to those in the “fiddlehead” mutants. From day 18, all the flowers appear normal again because flufenacet is degraded by the glutathione S-transferase activity of the plants.
- FDH FIDDLEHEAD
- Selected, mutated VLCFAE gene constructs are cloned into suitable pBIN vector constructs and transferred to suitable agrobacteria strains.
- the vector sequences harbour a marker gene which can be selected in plants and which confers, for example, resistance to kanamycin or resistance to the herbicide BASTA.
- Arabidopsis plants are grown and, after 4-6 weeks, shortly before flowering, immersed in a suspension of the agrobacteria strain transformed with the vector construct. Contact of the plant tissue with the bacteria suspension can be enhanced by vacuum infiltration. The plants treated in this way are incubated further until the seeds are ripe. The seeds are harvested and placed on selection medium.
- FIG. 1 Phylogenetic tree of Arabidopsis thaliana beta-ketoacyl-CoA synthases with homology to FIDDLEHEAD (FDH) (DNA Star Program MegAlign (Clustal method with PAM250 “residue weight table”)).
- SEQ ID NO: 1 Nucleic acid sequence coding for the “FIDDLEHEAD” (FDH) polypeptide from Arabidopsis thaliana, a very long chain fatty acid elongase. This is a genomic sequence, which is why introns are still present. The coding regions are indicated.
- FDH FIDDLEHEAD
- SEQ ID NO: 2 Amino acid sequence of the “FIDDLEHEAD” (FDH) polypeptide from Arabidopsis thaliana.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Developmental Biology & Embryology (AREA)
- Plant Pathology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Botany (AREA)
- Pathology (AREA)
- Environmental Sciences (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The invention relates to the use of nucleic acids which code for plant polypeptides with the biological activity of very long chain fatty acid elongases and to the use of the polypeptides encoded thereby for identifying novel, herbicidally active compounds, and to methods for finding modulators of these polypeptides.
Description
- The invention relates to the use of nucleic acids which code for plant polypeptides with the biological activity of very long chain fatty acid elongases and to the use of the polypeptides encoded thereby for identifying novel, herbicidally active compounds, and to methods for finding modulators of these polypeptides.
- Fatty acid elongases are also referred to as 3-ketoacyl-CoA-synthases or as “condensing enzymes”. Very long chain fatty acid elongases, abbreviated to VLCFAE hereinafter, are responsible for the biosynthesis of fatty acids with a chain length of more than 18 C atoms.(Millar, A. A. and Kunst, L. 1997, The Plant Journal 12(1), 121-131). The substrates recognized by VLCFAE apart from malonyl-CoA ester are only fatty acid-CoA esters with chain lengths of greater than or equal to C18 (C 18+), and the proteins are probably microsomally associated in the cytoplasm. Synthesis of fatty acids with up to 18 C atoms de novo in plants takes place in the chloroplast, and the fatty acids are esterified by an acyl carrier protein (ACP), (WO 98/54954). Long-Chain Fatty Acids, referred to as VLCFA hereinafter, are components and precursors of the wax layer in the cuticle of plants. They may be components and precursors of cell membranes or constituents of specific storage triacylglycerides. However, they may also be constituents or precursors of lipids with a signal function or with a second messenger function in the plant, such as, for example, the sphingolipids. (Millar, A. A. and Kunst, L. 1997, The Plant Journal 12(1), 121-131, Millar et al. 2000, Trends in Plant Science 5, 95-101).
- Biochemical research (Matthes et al., Z. Naturforsch. 1998, 53c, 1004-1011, Abulnaja and Harwood, Phytochemistry 1991, 30(5), 1445-1447) has revealed that herbicidal substance classes such as, for example, chloroacetamides, oxyacetamides and thiocarbamates inhibit the synthesis of long-chain fatty acids. However, this research did not show whether this takes place by direct inhibition of or interaction with fatty arid elongase enzymnes. It is equally unclear which of the many elongases which occur in plants are inhibited. Biochemical and cell biology research have further revealed that compounds such as BAS 13-338 inhibit C18:1 fatty acid elongation (Möller and Albrecht 1994, J. Plant Physiol. 144, 376-384). The elongases involved were also unknown in this research.
- VLCFAE are plant-specific genes which, for example in Arabidopsis, represent a complex family of genes. One gene in this family, fiddlehead, is specifically expressed in the epidermis, the outermost plant cell layer, and suppresses the dedifferentiation of these cells. Mutants in which the function of the FIDDLEHEAD-protein is impaired show fusions/adhesions of leaves and flower organs. The fusions/adhesions of the flower organs of a fiddlehead mutant resemble the scroll of a violin and gave this name to the mutant. Fiddlehead plants show considerable morphological changes and great impairments of development. (Lolle et al. 1992, Developmental Biology 152, 383-392, Yephremov et al. 1999, The Plant Cell 11, 2187-2201, Pruitt et al. 2000, PNAS 97(3), 1311-1316). Epidermal cells are essentially involved in the fusion/adhesion. Moreover the cells fuse only via the extracellular layer, without fusion of the cytoplasm. Since epidermal cells are responsible for the formation of the extracellular cuticle, it must be assumed that the loss of function of fiddlehead leads to a change in the VLCFA components in the cuticle and this causes the organ fusions described.
- The nucleic acid coding for the FIDDLEHEAD polypeptide is available under the accession number AJ010713 or O64846 (GenEMBL) and is shown in WO 98/54954 and described in the present application under SEQ ID NO: 1.
- The diversity of the elongases, their substrate specificity and their tissue-specific expression makes it possible for plants to produce a wide variety of storage, cuticle and signal lipids. This synthetic diversity can be utilized in practice through heterologous gene expression in transgenic plants. It is moreover possible by gene transfer for the synthetic capacity due to an elongase with specific substrate specificity to be transferred from one plant species to another. On the other hand, it is also possible, for example by exchange of promoters, for the tissue-specific lipid synthesis to be deliberately changed within one plant species. Diverse publications deal with research of this type. (see, for example, WO 96/13582, WO 98/46766, WO 98/54954, WO 95/15387, WO 00/08172).
- It has now been found, surprisingly, that the fiddlehead phenotype can be induced with a herbicidal active substance from the oxyacetamide class, flufenacet. The active substance phenocopies fiddlehead. In addition, the active substance also leads to fusion of the rosette leaves.
- The finding that the oxyacetamide flufenacet induces fiddlehead-like fusion of flower organs leads to the conclusion that FIDDLEHEAD (FDH), a very long chain fatty acid elongase, is the interaction partner (the target) of the herbicidal active substance.
- Since the VLCFAE, in particular also FIDDLEHEAD from Arabidopsis and other plants, show extensive homologies with one another, it is also possible to use homologous polypeptides encoded by appropriate homologous nucleic acids, and other members of the gene family, as molecular interaction partners (targets) for herbicidal active substances and the aforementioned class of substances. It is thus possible for herbicidal active substances to interact with various VLCFAE, although the interaction with the various VLCFAE occurring in plants may not always have the same strength. This might explain inter alia the observed selectivity of the herbicide class. Other members of the gene family, such as fatty acid elongases and beta-ketoacyl-CoA synthases from Arabidopsis, which are homologous with FIDDLEHEAD (FDH) from Arabidopsis thaliana (Acc. No. AJ010713 or O64846) are listed by way of example and not definitively in the following table and in
FIG. 1 . The degree of phylogenetic relationship between the genes shown can also be inferred qualitatively therefrom.Gene (Arabidopsis thaliana) Accession Number Description 1 T1D16.11 trembl|AC004484|AC004484_11 putative beta-ketoacyl-CoA synthase 2 F18A8.1 trembl|AC003105|AC003105_1 putative beta-ketoacyl-CoA synthase 3 F16F14.22 trembl|AC007047|AC007047_19 putative beta-ketoacyl-CoA synthase 4 F20D22.1 trembl|AC002411|AC002411_1 putative 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41) 5 CUT1 trembl|AF129511|AF129511_1 “very-long-chain fatty acid condensing enzyme” (CUT1) 6 KCS1 trembl|AF053345|AF053345_1 fatty acid elongase 3-ketoacyl-CoA- synthase 1-gene (“KCS1”); KCS1- Product: “fatty acid elongase 3- ketoacyl- CoA synthase 1”.7 AT4g34510 tremblnew|AL161585|ATCHRIV81_35 putative ketoacyl-CoA synthase 8 T3A4.10 trembl|AC005819|AC005819_10 putative beta-ketoacyl-CoA synthase 9 AT4g34250 tremblnew|AL161585|ATCHRIV81_9 fatty acid elongase- like protein 10 AT4g34520 tremblnew|AL161585|ATCHRIV81_36 fatty acid elongase 1 (FAE 1) (FAE 1) 11 F14P13.12 trembl|AC009400|AC009400_12 putative fatty acid elongase 3-ketoacyl- CoA synthase 112 F4F15.270 trembl|AL049711|ATF4F15_27 beta-ketoacyl-CoA synthase-like protein 13 T8O18.8 trembl|AC007171|AC007171_8 putative fatty acid elongase - A conclusion in the publication by Böger et al. 2000 (Pest Manag. Sci. 56, 497-508) is that plant VLCFAE are the primary targets of chloroacetamides.
- However, it is found in the present application for the first time by the example of the FIDDLEHEAD VLCFAE that VLCFAE are protein targets for herbicidal active substances and can be employed to identify novel, improved herbicidal active substances in methods (assays) suitable for this purpose.
- This applies in particular to polypeptides from plants showing a homology to the FIDDLEHEAD (FDH) polypeptide from Arabidopsis, preferably encompassing polypeptides with a homology of 60%, particularly preferably of 80% and very particularly preferably of 90%, to FDH.
- Particular preference is given in this connection to FDH-homologous VLCFAE from Arabidopsis for identifying novel, herbicidal active substances, preferably encompassing polypeptides with a homology of 60%, particularly preferably of 80% and very particularly preferably of 90%, to FDH.
- It is possible in a very particularly preferred manner for the FDH polypeptide from Arabidopsis to be used to identify novel herbicidal active substances.
- The present invention therefore relates to the use of plant polypeptides with the biological activity of a VLCFAE for identifying VLCFAE modulators.
- The present invention likewise relates to the use of plant polypeptides with the biological activity of a VLCFAE having a homology of 60%, preferably of 80% and particularly preferably of 90% to the FDH polypeptide from Arabidopsis for identifying VLCFAE modulators.
- The present invention likewise relates to the use of polypeptides from Arabidopsis with the biological activity of a VLCFAE which have a homology of 60%, preferably of 80% and particularly preferably of 90% to the FDH polypeptide from Arabidopsis for identifying VLCFAE modulators.
- The present invention relates in particular to the use of the FIDDLEHEAD polypeptide having SEQ ID NO: 2 for identifying VLCFAE modulators.
- The present invention likewise relates to the use of nucleic acids encoding for VLCFAE for identifying VLCFAE modulators.
- The present invention likewise relates to the use of nucleic acids coding for VLCFAE and having a homology to the fiddlehead sequence according to a coding sequence of SEQ ID NO: 1 of 60%, preferably of 80% and particularly preferably of 90% for identifying VLCFAE modulators. Homologues of Arabidopsis are particularly preferred in this connection.
- The present invention relates in particular also to the use of the nucleic acid coding for the FIDDLEHEAD polypeptide and having SEQ ID NO: 1 for identifying VLCFAE modulators.
- The polynucleotides or polynucleotide fragments to be used according to the invention are preferably those corresponding to polynucleotides from plants.
- The polynucleotides or polynucleotide fragments to be used according to the invention are particularly preferably those corresponding to polynucleotides from Arabidopsis.
- The polypeptides to be used according to the invention very particularly preferably include a sequence selected from
-
- a) the sequence shown in SEQ ID NO: 2,
- b) sequences encoded by a nucleic acid having SEQ ID NO: 1,
- c) partial sequences of the sequences defined under a) or b) which still have the biological activity of a VLCFAE,
- d) sequences which have an identity of at least 60%, preferably of 80%, particularly preferably of 90%, with the sequences defined under a) to c),
- e) sequences which include the C-terminally localized active site of the polypeptide shown in SEQ ID NO: 2,
- f) sequences which have an identity of at least 60%, preferably of 80%, particularly preferably of 90%, with the sequences defined under e),
- g) sequences which include the specific N terminus of the polypeptide shown in SEQ ID NO: 2, and
- h) sequences which have an identity of at least 60%, preferably of 80%, particularly preferably of 90%, with the sequences defined under g).
- A very particularly preferred embodiment of the nucleic acids to be used according to the invention is represented by a cDNA molecule having the FDH-encoding sequence shown in SEQ ID NO: 1, the introns shown in SEQ ID NO: 1 no longer being present.
- The FDH-encoding regions of the nucleic acid shown in SEQ ID NO: 1 extend from position 176-583, 1119-1745 and 1821-2438.
- The nucleic acids to be used according to the invention are, in particular, single-stranded or double-stranded deoxyribonucleic acids (DNA) or ribonucleic acids (RNA). Preferred embodiments are fragments of genomic DNA, which may contain introns as shown in SEQ ID NO: 1 and cDNAs.
- The nucleic acids to be used according to the invention are preferably DNA or DNA fragments corresponding to genomic DNA from plants.
- The nucleic acids to be used according to the invention are particularly preferably DNA or DNA fragments corresponding to genomic DNA from Arabidopsis.
- The nucleic acids to be used according to the invention very particularly preferably include a sequence selected from
-
- a) the sequence shown in SEQ ID NO: 1,
- b) sequences which code for a polypeptide including the amino acid sequence shown in SEQ ID NO: 2,
- c) partial sequences at least 14 base-pairs long of the sequences defined under a) or b),
- d) sequences which hybridize to the sequences defined under a) or b),
- e) sequences which have an identity of at least 60%, preferably of 80%, particularly preferably of 90%, with the sequences defined under a) or b),
- f) sequences which code for the C-terminally localized active site of the polypeptide shown in SEQ ID NO: 2
- g) sequences which have an identity of at least 60%, preferably of 80%, particularly preferably of 90%, with the sequences defined under f),
- h) sequences which code for the specific N terminus of the polypeptide shown in SEQ ID NO: 2,
- i) sequences which have an identity of at least 60%, preferably of 80%, particularly preferably of 90%, with the sequences defined under h),
- j) sequences which are complementary to the sequences defined under a) to i), and
- k) sequences which, because of the degeneracy of the genetic code, code for the same amino acid sequence as the sequences defined under a) to h).
- A very particularly preferred embodiment of the nucleic acids to be used according to the invention is represented by a cDNA molecule with the FDH-encoding sequence shown in SEQ ID NO: 1.
- The term “to hybridize” as used herein describes the process in which a single-stranded nucleic acid molecule enters into base pairing with a complementary strand. It is possible in this way, starting from the sequence information disclosed herein, for example to isolate DNA fragments from plants other than Arabidopsis which code for VLCFAE and, in particular, for FIDDLEHEAD, which have the same or similar properties of an elongase with the amino acid sequence shown in SEQ ID NO: 2. Thus, for example, the nucleic acid sequence coding for the N-terminal polypeptide sequence characteristic of FDH can be used in order to find nucleic acid sequences and polypeptides which are sequentially and functionally homologous to FDH and are suitable for identifying novel herbicidal active substances.
- Hybridization conditions are calculated approximately by the following formula:
- The melting temperature Tm=81.5° C.+16.6 log [c(Na+)]+0.41(% G+C))−500/n (Lottspeich and Zorbas, 1998).
- In this, c is the concentration and n is the length of the hybridizing sequence section in basepairs. The
term 500/n is omitted for a sequence of >100 bp. With the highest stringency, washing is carried out at a temperature of 5-15° C. below Tm and an ionic strength of 15 mM Na+ (equivalent to 0.1×SSC). If an RNA probe is used for the hybridization, then the melting point is 10-15° C. higher. - Preferred hybridization conditions are indicated below:
- Hybridization solution: DIG Easy Hyb (supplied by Roche) Hybridization temperature: 37° C., preferably 42° C. (DNA-DNA), 50° C. (DNA-RNA).
-
- 1. washing step: 2×SSC, 0.1
% SDS 2×5 min at room temperature; - 2. washing step: 1×SSC, 0.1
% SDS 2×15 min at 50° C.; preferably 0.5×SSC, 0.1% SDS 2×15 min at 65° C.; particularly preferably 0.2×SSC, 2×5 min at 68° C.
- 1. washing step: 2×SSC, 0.1
- The term “active site” refers to a peptide region which functionally corresponds to the peptide region with an amino acid sequence from position 191 to position 310 of the sequence shown in SEQ ID NO: 2. The reactive amino acid cystein is located at position 257.
- The degree of identity of the nucleic acids is preferably determined with the aid of the NCBI BLASTN program, version 2.0.4. (Altschul et al., 1997).
- The present invention also relates to the use, in methods for identifying VLCFAE inhibitors, of the regulatory regions which, in plant cells, especially in Arabidopsis, naturally control the transcription of the nucleic acids to be used according to the invention.
- The term “regulatory regions” as used herein refers to nontranslated regions of the relevant gene, such as promoters, enhancers, repressor or activator binding sites or termination sequences, which interact with cellular proteins, leading to control of transcription.
- The present invention further relates to the use of DNA constructs which include a nucleic acid to be used according to the invention and a heterologous promoter for identifying VLCFAE modulators.
- The term “heterologous promoter” as used herein refers to a promoter which has properties different from those of the promoter which controls expression of the relevant gene in the original organism.
- The selection of heterologous promoters depends on whether prokaryotic or eukaryotic cells or cell-free systems are used for expression. Examples of heterologous promoters are the 35S promoter of cauliflower mosaic virus for plant cells, the alcohol dehydrogenase promoter for yeast cells, the T3, T7 or SP6 promoters for prokaryotic cells or cell-free systems, and tissue-specific promoters from plants, for example the epidermis-specific promoter of FIDDLEHEAD and the promoters of other tissue-specific elongases.
- The present invention further relates to the use of vectors which contain a nucleic acid to be used according to the invention, a regulatory region to be used according to the invention or a DNA construct to be used according to the invention, in methods for identifying the VLCFAE modulators.
- Vectors which can be used are all phages, plasmids, phagemids, phasmids, cosmids, YACs, BACs, artificial chromosomes or particles suitable for particle bombardment which are used in molecular biology laboratories.
- Preferred vectors are pBIN (Bevan, 1984) and its derivatives for plant cells, pFL61 (Minet et al., 1992) or, for example, the p4XXprom vector series (Mumberg D., Müller R. and Funk M. 1995, Gene 156, 119-122) for yeast cells, pBLUESCRIPT-vectors for bacterial cells, lamdaZAP (from Stratagene) for phages.
- The present invention also relates to the use of host cells which contain a nucleic acid to be used according to the invention, a DNA construct to be used according to the invention or a vector to be used according to the invention, for identifying VLCFAE modulators.
- The term “host cell” as used herein refers to cells which do not naturally contain the nucleic acids to be used according to the invention and are suitable for expression of the polypeptide to be used according to the invention.
- Suitable host cells are both prokaryotic cells, preferably E. coli, and eukaryotic cells such as cells of Saccharomyces cerevisiae, Pichia pastoris, insects, plants, frog oocytes and mammalian cell lines.
- The term “polypeptides” as used herein refers both to short amino acid chains, which are usually referred to as peptides, oligopeptides or oligomers, and to longer amino acid chains which are usually referred to as proteins. It encompasses amino acid chains which may be modified either by natural processes, such as post-translational processing, or by chemical methods which are state of the art. Such modifications may occur at various points and a plurality of times in a polypeptide, such as, for example, on the peptide backbone, on the amino acid side chain, on the amino terminus and/or on the carboxyl terminus. They comprise, for example, acetylations, acylations, ADP ribosylations, amidations, covalent linkages with flavins, haem portions, nucleotides or nucleotide derivatives, lipids or lipid derivatives or phosphatidylinositol, cyclizations, formation of disulphide bridges, demethylations, cystine formations, formylations, gamma-carboxylations, glycosylations, hydroxylations, iodinations, methylations, myristoylations, oxidations, proteolytic processings, phosphorylations, selenoylations and tRNA-mediated additions of amino acids.
- The peptides according to the invention may be in the form of “mature” proteins or in the form of parts of larger proteins, for example as fusion proteins. They may furthermore have secretion or “leader” sequences, prosequences, sequences which make simple purification possible, such as multiple histidine residues, or additional stabilizing amino acids.
- The polypeptides to be used according to the invention need not be complete VLCFAE but may also be only fragments thereof as long as they still have a biological activity of the complete VLCFAE. Polypeptides which exercise a biological activity of the same type as a VLCFA-E with an amino acid sequence as shown in SEQ ID NO: 2 are also regarded as being according to the invention. The polypeptides to be used according to the invention moreover need not correspond to the VLCFAE from Arabidopsis. Also regarded as polypeptides to be used according to the invention are polypeptides which are homologous to VLCFAE for example of the following plants or to fragments thereof which can still exercise the biological activity of the latter:
- Dicotyledonous plants of the genera: Abutilon, Amaranthus, Ambrosia, Anoda, Anthemis, Aphanes, Atriplex, Bellis, Bidens, Capsella, Carduus, Cassia, Centaurea, Chenopodium, Cirsium, Convolvulus, Datura, Desmodium, Emex, Erysimum, Euphorbia, Galeopsis, Galinsoga, Galium, Hibiscus, Ipomoea, Kochia, Lamium, Lepidium, Lindemia, Matricaria, Mentha, Mercurialis, Mullugo, Myosotis, Papaver, Pharbitis, Plantago, Polygonum, Portulaca, Ranunculus, Raphanus, Rorippa, Rotala, Rumex, Salsola, Senecio, Sesbania, Sida, Sinapis, Solanum, Sonchus, Sphenoclea, Stellaria, Taraxacum, Thlaspi, Trifolium, Urtica, Veronica, Viola, Xanthium.
- Dicotyledonous plants of the genera: Arachis, Beta, Brassica, Cucumis, Cucurbita, Helianthus, Daucus, Glycine, Gossypium, Ipomoea, Lactuca, Linum, Lycopersicon, Nicotiana, Phaseolus, Pisum, Vicia.
- Monocotyledonous plants of the genera: Aegilops, Agropyron, Agrostis, Alopecurus, Apera, Avena, Brachiaria, Bromus, Cenchrus, Commnelina, Cynodon, Cyperus, Dactyloctenium, Digitaria, Echinochloa, Eleocharis, Eleusine, Eragrostis, Eriochloa, Festuca, Fimbristylis, Heteranthera, Imperata, Ischaemum, Leptochloa, Lolium, Monochoria, Panicum, Paspalum, Phalaris, Phleum, Poa, Rottboellia, Sagittaria, Scirpus, Setaria, Sorghum.
- Monocotyledonous plants of the genera: Allium, Ananas, Asparagus, Avena, Hordeum, Oryza, Panicum, Saccharurn, Secale, Triticale, Triticum, Zea.
- The polypeptides to be used according to the invention may, by comparison with the corresponding region of naturally occurring VLCFAE, have deletions or amino acid substitutions as long as they still exercise the biological activity of the complete fatty acid elongases. Conservative substitutions are preferred. Such conservative substitutions comprise variations where one amino acid is replaced by another amino acid from the following group:
-
- 1. small aliphatic residues which are nonpolar or of low polarity: Ala, Ser, Thr, Pro and Gly;
- 2. polar, negatively charged residues and their amides: Asp, Asn, Glu und Gln;
- 3. polar, positively charged residues: His, Arg and Lys;
- 4. large aliphatic, nonpolar residues: Met, Leu, Ile, Val and Cys; and
- 5. aromatic residues: Phe, Tyr und Trp.
- The following list shows preferred conservative substitutions:
Original residue Substitution Ala Gly, Ser Arg Lys Asn Gln, His Asp Glu Cys Ser Gln Asn Glu Asp Gly Ala, Pro His Asn, Gln Ile Leu, Val Leu Ile, Val Lys Arg Met Leu, Tyr, Ile, Phe Phe Met, Leu, Tyr, Trp Ser Thr Thr Ser Trp Tyr, Phe Tyr Trp, Phe Val Ile, Leu - The present invention thus also relates to the use of polypeptides which exercise the biological activity of a VLCFAE and comprise an amino acid sequence which shows at least 60% identity, preferably 80% identity, particularly preferably 90% identity and particularly preferably 97-99% identity with the sequence shown in SEQ ID NO: 2 over the entire length thereof.
- The degree of identity of the amino acid sequences is preferably determined with the aid of the BLASTP+BEAUTY programme, version 2.0 4. (Altschul et al., 1997).
- A preferred embodiment of the polypeptides to be used according to the invention is the VLCFAE FIDDLEHEAD (FDH) with an amino acid sequence as shown in SEQ ID NO: 2.
- The FDH amino acid sequence belongs on the basis of homology (Yephremov et al. 1999) to the family of fatty acid elongases (FAE). The FDH protein has two potential transmembranes domains in the region of the amino acids from about 53 to 75 and in the region from about 93 to 115.
- The first 45-50 amino acids at the N terminus are specific for the FIDDLEHEAD protein whose biological role has not as yet been fully elucidated. The N terminus is so specific that it can be used as recognition sequence for FDH.
- The term “biological activity of a VLCFAE” as used herein means the ability to biosynthesize fatty acids with a chain length of 18 and more C atoms, and to the recognition of the substrates malonyl-CoA esters and/or fatty acid CoA esters with chain lengths greater than or equal to C18.
- The nucleic acids to be used according to the invention can be prepared in the conventional way. For example, the nucleic acid molecules can be completely chemically synthesized. It is also possible for short pieces of the nucleic acids according to the invention to be chemically synthesized and for such oligonucleotides to be labelled radioactively or with a fluorescent dye. The labelled oligonucleotides can also be used to screen cDNA banks produced starting from plant mRNA. Clones to which the labelled oligonucleotides hybridize are selected for isolating the relevant DNA fragments. After characterization of the isolated DNA, the nucleic acids to be used according to the invention are obtained in a simple manner.
- The nucleic acids to be used according to the invention can also be prepared by PCR methods using chemically synthesized oligonucleotides.
- The term “oligonucleotide(s)” as used herein means DNA molecules consisting of 10 to SO nucleotides, preferably 15 to 30 nucleotides. They are chemically synthesized and can be used as probes.
- The polypeptides to be used according to the invention which are encoded by the nucleic acids according to the invention can be prepared by cultivating, under suitable conditions, host cells which contain nucleic acids to be used according to the invention. The desired polypeptides can then be isolated in a conventional way from the cells or the culture medium. The polypeptides can also be prepared in in-vitro systems.
- A rapid method for isolating the polypeptides to be used according to the invention which are synthesized by host cells using a nucleic acid to be used according to the invention starts with the expression of a fusion protein where the fusion partner can be affinity-purified in a simple manner. The fuision partner can be, for example, glutathione S-transferase. The fusion protein can then be purified on a glutathione affinity column. The fusion partner can be removed by partial proteolytic cleavage for example at linkers between the fusion partner and the polypeptide according to the invention which is to be purified. The linker can be designed so that it includes target amino acids, such as arginine and lysine residues, which define sites for trypsin cleavage. Such linkers can be generated by employing standard cloning methods using oligonucleotides.
- Further possible purification methods are based on preparative electrophoresis, FPLC, HPLC (for example using gel filtration, reverse phase or slightly hydrophobic columns), gel filtration, differential precipitation, ion exchange chromatography and affinity chromatography.
- Since VLCFAE are membrane proteins or membrane-associated proteins, detergent extractions are preferably carried out during the purification methods, for example using detergents which affect the secondary and tertiary structures of the polypeptides only slightly or not at all, such as nonionic detergents.
- Purification of the polypeptides to be used according to the invention may encompass the isolation of membranes starting from host cells which express the nucleic acids according to the invention. Such cells preferably express the polypeptides to be used according to the invention in an adequate copy number so that the amount of polypeptides in a membrane fraction is at least 10 times higher than that found in comparable membranes of cells which express the FDH gene naturally; the amount is particularly preferably 100 times, very particularly preferably at least 1000 times, higher.
- For assay purposes it is also possible for a membrane fraction, in particular a microsome fraction, to be concentrated and used without special purification.
- The terms “isolation or purification” as used herein mean that the polypeptides to be used according to the invention are separated from other proteins or other macromolecules of the cell or of the tissue. A composition containing the polypeptides to be used according to the invention is preferably concentrated at least 10-fold and particularly preferably at least 100-fold in terms of the protein content by comparison with a preparation from the host cells.
- The polypeptides to be used according to the invention can be affinity-purified even without fusion partners, with the aid of antibodies which bind to the polypeptides.
- The present invention also relates to methods for finding chemical compounds which bind to the polypeptides according to the invention and alter their properties. Because of the diverse functions of the VLCFAE according to the invention, modulators which influence the activity may represent novel growth-regulating or herbicidal active substances. Modulators may be agonists or antagonists, or inhibitors or activators.
- The term “agonist” as used herein refers to a molecule which promotes or enhances the VLCFAE activity.
- The term “antagonist” as used herein refers to a molecule which retards or impedes the VLCFAE activity.
- The term “modulator” as used herein represents the generic term for agonist and antagonist. Modulators may be small organic chemical molecules, peptides or antibodies which bind to/the polypeptides according to the invention. Modulators may furthermore be small organic chemical molecules, peptides or antibodies which bind to a molecule which in turn binds to the polypeptides according to the invention and thus influences their biological activity. Modulators may be natural substrates and ligands or structural or functional mimetics thereof.
- The modulators are preferably small organic chemical compounds.
- Binding of the modulators to the VLCFAE may alter the cellular processes in a way leading to death of the plants treated therewith.
- The present invention therefore also relates to VLCFAE modulators which have been found with the aid of a method described above for identifying modulators of the FDH protein or of a VLCFAE homologous thereto.
- The present invention further relates to methods for finding chemical compounds which alter the expression of the polypeptides to be used according to the invention. Such “expression modulators” may also represent novel growth-regulating or herbicidal active substances. Expression modulators may be small organic chemical molecules, peptides or antibodies which bind to the regulatory regions of the nucleic acids coding for the polypeptides to be used according to the invention. Expression modulators may furthermore be small organic chemical molecules, peptides or antibodies which bind to a molecule which in turn binds to regulatory regions of the nucleic acids coding for the polypeptides to be used according to the invention, and thus influences expression thereof. Expression modulators may also be antisense molecules.
- The present invention likewise relates to the use of modulators of the polypeptides to be used according to the invention or of expression modulators as plant growth regulators or herbicides.
- The present invention likewise relates to expression modulators of VLCFAE which are found with the aid of the method described above for finding expression modulators.
- The methods according to the invention include high-throughput screening (HTS). It is possible to use for this both host cells and cell-free preparations which contain the nucleic acids to be used according to the invention and/or the polypeptides to be used according to the invention.
- In order to find modulators it is possible to incubate a synthetic reaction mix (for example products of in vitro transcription) or a cellular constituent, such as a membrane or any other preparation which contains the polypeptides to be used according to the invention, together with a labelled substrate or ligand of the polypeptides in the presence and absence of a candidate molecule which may be an agonist or antagonist. The ability of the candidate molecule to increase or inhibit the activity of the polypeptides to be used according to the invention is evident from an increased or reduced binding of the labelled ligand or from an increased or reduced conversion of the labelled substrate. Molecules which bind well and lead to an increased activity of the polypeptides according to the invention are agonists. Molecules which bind well and inhibit the biological activity of the polypeptides to be used according to the invention are good antagonists. These may be inhibitors of the abovementioned classes of herbicidal substances without, however, being restricted thereto.
- Detection of the biological activity of the polypeptides to be used according to the invention can be improved by a so-called reporter system. Reporter systems in this regard comprise, but are not restricted to, calorimetrically labelled substrates which are converted into a product, or a reporter gene which responds to changes in the activity or the expression of the polypeptides to be used according to the invention, or other known binding assays.
- The activity of membrane-associated proteins can advantageously be measured in another way. Functional heterologous expression of such proteins in E coli is often difficult or impossible. In this case it is possible by suitable cloning (for example using suitable PCR strategies) to separate the catalytically active part of the protein from the membrane-associated part of the protein so that the gene product represents a soluble protein and can easily be purified. A wide repertoire of measurement possibilities is available for measuring the activity of soluble proteins. Particularly sensitive measurement can take place for example by fluorescence polarization with use of a fluorescence-labelled ligand or substrate.
- Another example of a method with which modulators of the polypeptides to be used according to the invention can be found is a displacement assay in which, under conditions suitable for this purpose, the polypeptides to be used according to the invention and a potential modulator are compacted with a molecule which is known to bind to the polypeptides to be used according to the invention, such as a natural substrate or ligand or a substrate or ligand mimetic. The substrate or ligand mimetic may be, for example, radioactively labelled or provided with a fluorescent or dye marker (also UV). The polypeptides to be used according to the invention themselves can also be labelled in an analogous way so that the number of polypeptides which are bound to a ligand or have undergone a reaction can be determined accurately. It is possible in this way to estimate the efficacy of an agonist or antagonist.
- The invention further relates to the use of a nucleic acid to be used according to the invention, of a DNA construct to be used according to the invention or of a vector to be used according to the invention for producing transgenic plants, and to the corresponding transgenic plants as such or parts or propagation material thereof.
- The present invention likewise relates to transgenic plants, parts of plants, protoplasts, plant tissues or plant propagation materials in which, after introduction of a nucleic acid to be used according to the invention, of a DNA construct to be used according to the invention or of a vector to be used according to the invention, the intracellular concentration of VLCFAE is increased or reduced compared with the corresponding wild-type forms.
- The term “parts of plants” as used herein means all epigeal and hypogeal parts and organs of the plants, such as shoot, leaf, flower and root, and protoplasts and tissue cultures produced therefrom.
- The term “propagation material” as used herein means vegetative and generative propagation material such as cuttings, tubers, rhizomes, layers and seeds.
- The invention also relates to plants in which alterations are made in the sequence coding for VLCFAE leading to production of a VLCFAE which leads to an increase or reduction in the biological activity or the amount of the VLCFAE present in the plants.
- The term “mutagenesis” as used herein refers to a method for increasing the spontaneous mutation rate and thus for isolating mutants. This may entail generation of mutants with the aid of mutagens in vivo, for example with chemical compounds or physical effects which are suitable for inducing mutations (for example base analogues, intercalating substances, UV rays etc.). The required mutants can be obtained by selection for a particular phenotype. The position of the mutations on the chromosomes can be determined relative to other known mutations by complementation and recombination analyses. Mutations can also be introduced in a targeted manner into chromosomal or extrachromosomal DNA (in vitro mutagenesis, site directed mutagenesis, error-prone PCR etc.).
- The term “mutant” as used herein refers to an organism which harbours an altered (mutated) gene. A mutant is defined by comparison with the wild-type which harbours the unaltered gene.
- Since the VLCFAE to be used according to the invention, in particular the FDH protein, plays a part in signalling and development processes, transgenic “sense” plants or plants which have been selected deliberately for an increased amount or activity of corresponding endogenous VLCFAE or elements linked thereto in the signal transduction acquire increased resistance to herbicidally active compounds. It is also possible by mutating the amino acid sequence to develop VLCFAE which are resistant to compounds having herbicidal activity on these proteins. Transfer and expression of the genes of such naturally isolated or synthetically produced mutants in plants, especially in crop plants such as, for example, maize, wheat, barley, oats, rice, rye, tomatoes, legumes, potato plants, Lactuca sativa, Brassicaceae, wood plants, Physcomitrella patens, makes them herbicide-resistant or characterized by increased tolerance to herbicides.
- Arabidopsis seeds (ecotype Columbia Col-0), which were stored at 4° C., were sown in soil and cultivated at 22° C.±2° C. under long-day conditions (16 h light/8 h dark).
-
Plants 2 weeks old were sprayed with 250 g/ha and 50 g/ha flufenacet and cultivated further at 22° C.±2° C. under long-day conditions (16 h light/8 h dark). Between day 7 and day 11 after flufenacet treatment, the flower organs fuse with the uppermost cauline leaves of the Arabidopsis plants. These fusions are very similar to those in the “fiddlehead” mutants. From day 18, all the flowers appear normal again because flufenacet is degraded by the glutathione S-transferase activity of the plants. - Isolation of the described FIDDLEHEAD (FDH) nucleotide sequence can take place in analogy to Yephremov et al. 1999, The Plant Cell 11, 2187-2201, Pruitt et al. 2000, PNAS 97(3), 1311-1316 or as described in WO 98/54954 (clone EL 4). The sequence can also be obtained straightforwardly by methods known to the skilled person with the assistance of the sequence described in SEQ ID NO: 1.
- Selected, mutated VLCFAE gene constructs are cloned into suitable pBIN vector constructs and transferred to suitable agrobacteria strains. The vector sequences harbour a marker gene which can be selected in plants and which confers, for example, resistance to kanamycin or resistance to the herbicide BASTA. Arabidopsis plants are grown and, after 4-6 weeks, shortly before flowering, immersed in a suspension of the agrobacteria strain transformed with the vector construct. Contact of the plant tissue with the bacteria suspension can be enhanced by vacuum infiltration. The plants treated in this way are incubated further until the seeds are ripe. The seeds are harvested and placed on selection medium. The only seedlings to survive are those containing the transferred gene construct and the marker gene, those which have thus been successfully transformed. A detailed description of the method can be found in Bechthold N. and Pelletier G.: In planta Agrobacterium mediated transformation of adult Arabidopsis thaliana plants by vacuum infiltration. In: Arabidopsis Protocols, edited by Martinez-Zapater J. M. and Salinas J., 1998 Humana Press ISBN 0-89603-391-0.
-
FIG. 1 : Phylogenetic tree of Arabidopsis thaliana beta-ketoacyl-CoA synthases with homology to FIDDLEHEAD (FDH) (DNA Star Program MegAlign (Clustal method with PAM250 “residue weight table”)). - SEQ ID NO: 1: Nucleic acid sequence coding for the “FIDDLEHEAD” (FDH) polypeptide from Arabidopsis thaliana, a very long chain fatty acid elongase. This is a genomic sequence, which is why introns are still present. The coding regions are indicated.
- SEQ ID NO: 2: Amino acid sequence of the “FIDDLEHEAD” (FDH) polypeptide from Arabidopsis thaliana.
- Abulnaja K. O. and Harwood J. L. 1991, Thiocarbamate Herbicides inhibit fatty acid elongation in a variety of monocotyledons. Phytochemistry 30(5), 1445-1447).
- Altschul S. F., Madden T. L., Schaffer A. A., Zhang J. Z.; Miller W. and Lipman, D. J. 1997. Gapped BLAST and PSI-BLAST generation of protein database search programs. Nucleic Acids Res. 25: 3389-3402.
- Bechthold N. und Pelletier G.: In planta Agrobacterium mediated transformation of adult Arabidopsis thaliana Plants by vacuum infiltration. In: Arabidopsis Protocols, edited by Martinez-Zapater J. M. und Salinas J., 1998 Humana Press ISBN 0-89603-391-0.
- Bevan, M., Binary Agrobacterium vectors for plant transformation (1984), Nucl. Acids Res. 12 (22), 8711-8721.
- Böger P., Matthes B. und Schmalfuβ J. 2000, Towards the primary target of chloroacetamides—new findings pave the way. Pest Management Science 56: 497-508.
- Lottspeich, F., Zorbas H. (editors). 1998. Bioanalytik. Spektrum Akademischer Verlag, Heidelberg, Berlin.
- Matthes B., Schmalfuβ J. and Boeger P. 1998, Chloracetamide Mode of Action II: Inhibition of Very Long Chain Fatty Acid Synthesis in Higher Plants. Z. Naturforsch. 53c, 1004-1011.
- Millar A. A. and Kunst L. 1997, Very-long-chain fatty acid biosynthesis is controlled through the expression and specificity of the condensing enzyme. The Plant Journal 12(1), 121-131.
- Millar A. A., Smith M. A., Kunst L. 2000, All fatty acids are not equal: discrimination in plant membrane lipids. Trends in
Plant Science 5, 95-101. - Minet, M., Dufour, M. -E. and Lacroute, F. 1992. Complementation of Saccharomyces cerevisiae auxotrophic mutants by Arabidopsis thaliana cDNAs. Plant J. 2: 417-422.
- Möllers C. and Albrecht S.1994, Screening herbicide effects on lipid metabolism of storage lipids by in vitro culture of microspore-derived embryoids of Brassica napus. J. Plant Physiol. 144, 376-384.
- Mumberg D., Müller R. and Funk M. 1995, Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds. Gene 156, 119-122.
- Pruitt R. E., Vielle-Calzada J -P., Ploense S. E., Grossniklaus U. and Lolle S. J. 2000, FIDDLEHEAD, a gene required to suppress epidermal cell interactions in Arabidopsis, encodes a putative lipid biosynthetic enzyme. PNAS 97(3), 1311-1316.
- Puissant, C. and Houdebine, L. -M. 1990. An improvement of the single-step method of the RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. BioTechniques 8: 148-149.
- Skoog, F., Miller, C. O. 1957. Chemical regeneration of growth and organ formation in plant tissue cultures in vitro. Symp. Soc. Exp. Biol. 11: 118-131.
- WO 2000/008172
- WO 95/15387
- WO 96/13 582
- WO 98/46766
- WO 98/54954
- Yephremov A., Wismann E., Huijser P., Huijser C., WellesenK, Saedler H. 1999, Characterization of the FIDDLEHEAD Gene of Arabidopsis reveals a link between adhesion response and cell differentiation in the epidermis. The Plant Cell 11, 2187-2201.
Claims (17)
1-24. (Cancelled).
25. A plant cell having a hetrologous nucleic acid stably integrated into its genome, said DNA comprising a heterologous nucleic acid encoding a polypeptide having the biological activity of a very long chain fatty acid elongase and having an identity of at least 90% to the sequence of SEQ ID NO:2.
26. The cell of claim 25 wherein said nucleic acid encodes a polypeptide having an increased enzymatic activity relative to the polypeptide of SEQ ID NO:2.
27. The cell of claim 25 wherein said nucleic acid encodes a polypeptide having a reduced enzymatic activity relative to the polypeptide of SEQ ID NO:2.
28. The cell of claim 25 wherein said nucleic acid also comprises a heterologous promoter and wherein said nucleic acid is under the control of said promoter.
29. The cell of claim 25 wherein the intracellular concentration of said polypeptide is increased relative to a wild-type plant cell expressing a polypeptide having the biological activity of a very long chain fatty acid elongase and having an identity of at least 90% to the sequence of SEQ ID NO:2.
30. The cell of claim 25 wherein the intracellular concentration of said polypeptide is reduced relative to a wild-type plant cell expressing a polypeptide having the biological activity of a very long chain fatty acid elongase and having an identity of at least 90% to the sequence of SEQ ID NO:2.
31. The cell of claim 25 wherein said nucleic acid encodes a polypeptide having an increased resistance to a herbicide, said herbicide having an activity on polypeptides having the biological activity of a very long chain fatty acid elongase.
32. The cell of claim 25 wherein said nucleic acid encodes a polypeptide having an increased resistance to a herbicide, said herbicide being flufenacet.
33. A plant which consists of the cells of claim 25 .
34. A plant which consists of the cells of claim 26 .
35. A plant which consists of the cells of claim 27 .
36. A plant which consists of the cells of claim 28 .
37. A plant which consists of the cells of claim 29 .
38. A plant which consists of the cells of claim 30 .
39. A plant which consists of the cells of claim 31 .
40. A plant which consists of the cells of claim 32.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/927,237 US20050019851A1 (en) | 2000-07-18 | 2004-08-26 | Use of VLCFAE for identifying herbicidally active compounds |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10034804A DE10034804A1 (en) | 2000-07-18 | 2000-07-18 | Use of VLCFAE to identify herbicidally active compounds |
DE10034804.1 | 2000-07-18 | ||
US09/905,657 US6849435B2 (en) | 2000-07-18 | 2001-07-13 | Use of VLCFAE for identifying herbicidally active compounds |
US10/927,237 US20050019851A1 (en) | 2000-07-18 | 2004-08-26 | Use of VLCFAE for identifying herbicidally active compounds |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/905,657 Division US6849435B2 (en) | 2000-07-18 | 2001-07-13 | Use of VLCFAE for identifying herbicidally active compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
US20050019851A1 true US20050019851A1 (en) | 2005-01-27 |
Family
ID=7649260
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/905,657 Expired - Fee Related US6849435B2 (en) | 2000-07-18 | 2001-07-13 | Use of VLCFAE for identifying herbicidally active compounds |
US10/926,527 Abandoned US20050009189A1 (en) | 2000-07-18 | 2004-08-26 | Use of VLCFAE for identifying herbicidally active compounds |
US10/927,237 Abandoned US20050019851A1 (en) | 2000-07-18 | 2004-08-26 | Use of VLCFAE for identifying herbicidally active compounds |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/905,657 Expired - Fee Related US6849435B2 (en) | 2000-07-18 | 2001-07-13 | Use of VLCFAE for identifying herbicidally active compounds |
US10/926,527 Abandoned US20050009189A1 (en) | 2000-07-18 | 2004-08-26 | Use of VLCFAE for identifying herbicidally active compounds |
Country Status (5)
Country | Link |
---|---|
US (3) | US6849435B2 (en) |
EP (1) | EP1174517B1 (en) |
JP (1) | JP2002360248A (en) |
AT (1) | ATE292370T1 (en) |
DE (2) | DE10034804A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10034804A1 (en) * | 2000-07-18 | 2002-01-31 | Bayer Ag | Use of VLCFAE to identify herbicidally active compounds |
EP1963501A4 (en) * | 2005-12-22 | 2009-04-22 | Pacific Biosciences California | Protein engineering strategies to optimize activity of surface attached proteins |
WO2007076057A2 (en) | 2005-12-22 | 2007-07-05 | Pacific Biosciences Of California, Inc. | Polymerases for nucleotide analogue incorporation |
AU2006331512B2 (en) * | 2005-12-22 | 2012-02-23 | Pacific Biosciences Of California, Inc. | Active surface coupled polymerases |
US8343746B2 (en) * | 2006-10-23 | 2013-01-01 | Pacific Biosciences Of California, Inc. | Polymerase enzymes and reagents for enhanced nucleic acid sequencing |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6307128B1 (en) * | 1997-06-03 | 2001-10-23 | Miami University | Fatty acid elongases |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5679881A (en) | 1991-11-20 | 1997-10-21 | Calgene, Inc. | Nucleic acid sequences encoding a plant cytoplasmic protein involved in fatty acyl-CoA metabolism |
AU703957B2 (en) | 1994-10-26 | 1999-04-01 | Cargill Incorporated | FAE1 genes and their uses |
AU750707C (en) | 1997-04-14 | 2003-05-15 | University Of British Columbia, The | Nucleic acids encoding a plant enzyme involved in very long chain fatty acid synthesis |
AU748943B2 (en) | 1998-08-03 | 2002-06-13 | Agricultural Technology & Genetics Gmbh | Method to alter the fatty acid metabolism in plants |
DE10034804A1 (en) * | 2000-07-18 | 2002-01-31 | Bayer Ag | Use of VLCFAE to identify herbicidally active compounds |
-
2000
- 2000-07-18 DE DE10034804A patent/DE10034804A1/en not_active Withdrawn
-
2001
- 2001-07-05 AT AT01115693T patent/ATE292370T1/en not_active IP Right Cessation
- 2001-07-05 EP EP01115693A patent/EP1174517B1/en not_active Expired - Lifetime
- 2001-07-05 DE DE50105808T patent/DE50105808D1/en not_active Expired - Fee Related
- 2001-07-13 US US09/905,657 patent/US6849435B2/en not_active Expired - Fee Related
- 2001-07-17 JP JP2001216441A patent/JP2002360248A/en active Pending
-
2004
- 2004-08-26 US US10/926,527 patent/US20050009189A1/en not_active Abandoned
- 2004-08-26 US US10/927,237 patent/US20050019851A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6307128B1 (en) * | 1997-06-03 | 2001-10-23 | Miami University | Fatty acid elongases |
Also Published As
Publication number | Publication date |
---|---|
US6849435B2 (en) | 2005-02-01 |
EP1174517A3 (en) | 2002-10-09 |
ATE292370T1 (en) | 2005-04-15 |
EP1174517B1 (en) | 2005-04-06 |
US20020038471A1 (en) | 2002-03-28 |
EP1174517A2 (en) | 2002-01-23 |
DE50105808D1 (en) | 2005-05-12 |
JP2002360248A (en) | 2002-12-17 |
US20050009189A1 (en) | 2005-01-13 |
DE10034804A1 (en) | 2002-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Léon et al. | The AtNFS2 gene from Arabidopsis thaliana encodes a NifS-like plastidial cysteine desulphurase | |
AU697331B2 (en) | Transgenic plants that exhibit enhanced nitrogen assimilation | |
Dubois et al. | Glutamate dehydrogenase in plants: is there a new story for an old enzyme? | |
CN105637091B (en) | Plants with enhanced tolerance to herbicides | |
US7692067B2 (en) | Yield and stress tolerance in transgenic plants | |
Zolman et al. | IBR3, a novel peroxisomal acyl-CoA dehydrogenase-like protein required for indole-3-butyric acid response | |
EP2287292A2 (en) | Plant derived hydroxy phenyl pyruvate dioxygneases (HPPD) resistant against triketone herbicides and transgenic plants containing these dioxygenases | |
US20030162294A1 (en) | Genes involved in tolerance to environmental stress | |
WO2004062351A2 (en) | Gene encoding resistance to acetolactate synthase-inhibiting herbicides | |
CA2918565A1 (en) | Improved yield and stress tolerance in transgenic plants with overexpressing polypeptides comprising a b-box zinc-finger domain | |
Jung et al. | Dual targeting of Myxococcus xanthus protoporphyrinogen oxidase into chloroplasts and mitochondria and high level oxyfluorfen resistance | |
US6849435B2 (en) | Use of VLCFAE for identifying herbicidally active compounds | |
Groszmann et al. | Manipulating gibberellin control over growth and fertility as a possible target for managing wild radish weed populations in cropping systems | |
US20060160700A1 (en) | Nadh-dependent cytochrome b5 reductase as target for herbicides | |
WO2014030090A1 (en) | Herbicide-metabolizing cytochrome p450 monooxygenase | |
WO2001018191A2 (en) | Polynucleotides and polypeptides of the phosphoenolpyruvate carboxylase kinase (pepc kinase) family and their variants | |
CA2318522A1 (en) | Riboflavin biosynthesis genes from plants and uses thereof | |
US6294345B1 (en) | Genes encoding proteins essential for plant growth and methods of use | |
Huang | The nonprotein amino acid meta-tyrosine: its biosynthesis, phytotoxicity, and application as a tool for research on aromatic amino acid metabolism in plants | |
CA2995275C (en) | Methods and compositions for herbicide tolerance in plants | |
Moreira | Unravelling the role of glutamine synthetase in seed development in Arabidopsis thaliana | |
JP2003525047A (en) | Aspartate carbamoyltransferase as a herbicide target | |
Woodward | Genes, organelles, and molecules that influence plant development through auxin regulation | |
KR20190044448A (en) | Use of GS gene from Brassica juncea as regulator of yield and environmental stresses | |
CA2495555A1 (en) | Method for identifying substances having a herbicide action |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |